EUVIMEDEUVIMED entdecken
Open Access

Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences PD-L1 Expression in Papillary Thyroid Carcinoma

Vitor Barreto Santana iD, Vitória Machado Krüger, Maria Cristina Yunes Abrahão, Pietru Lentz Martins Cantú, Rosicler Luzia Brackmann, Gisele Moroni Pandolfi, Liane Scheffler Marisco, Gabriela Remonatto, Luciana Adolfo Ferreira, Marcia Silveira Graudenz

Head and Neck Pathology · 2024

DOI: 10.1007/s12105-024-01618-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head and Neck Pathology, 2024. Verfasst von Vitor Barreto Santana und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos, Porto Alegre, 2350, 90035-903, Rio Grande do Sul, Brazil. vitor_barre…. Hauptthemen laut MEDLINE: Hashimoto Disease, Thyroid Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite the increasing recognition of PD-L1 as predictor of immunotherapeutic response in various malignancies, its role and prognostic significance in thyroid cancer remain underexplored and subject to debate. This study begins to address this gap by comprehensively analyzing PD-L1 expression in papillary thyroid carcinoma (PTC) and investigating its correlation with key clinicopathological variables. METHODS: We conducted immunohistochemistry (IHC) to assess PD-L1 expression in whole-tissue sections from 121 primary papillary thyroid carcinoma (PTC) cases. We then analyzed the correlations between PD-L1 expression and various clinicopathological variables. RESULTS: PD-L1 expression was detected in 33.1% of papillary thyroid carcinomas (PTCs), predominantly exhibiting weak to moderate intensity. Notably, this study found no significant correlation between PD-L1 expression and various clinicopathological variables. The lack of association with traditional factors such as age, sex, histological subtype, and tumor size suggests the complex and multifaceted nature of PD-L1 regulation in PTC. Multivariate logistic regression analysis identified chronic lymphocytic thyroiditis with oncocytic metaplasia as the sole independent predictor of PD-L1 expression (P = 0.014), underlining the potential influence of the tumor microenvironment on immune checkpoint expression in PTC. CONCLUSIONS: Our study underscores the intricate interplay between chronic lymphocytic thyroiditis with oncocytic metaplasia and PD-L1 expression in papillary thyroid carcinoma. The observed link suggests a potential avenue for therapeutic intervention using anti-PD-1/PD-L1 therapies in surgery-refractory PTC. Understanding the dynamics of immune checkpoint regulation in the context of the tumor microenvironment is crucial for devising effective treatment strategies. Future research endeavors should delve deeper into the molecular mechanisms underlying this interaction and explore its implications for patient outcomes. As the field of immunotherapy continues to evolve, our findings contribute valuable insights into the complex immunological landscape of thyroid cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hashimoto DiseaseThyroid NeoplasmsHumansThyroid Cancer, PapillaryB7-H1 AntigenMetaplasiaTumor Microenvironment

Stichwörter der Autor:innen

Chronic Lymphocytic ThyroiditisClinicopathological FeaturesExtrathyroidal ExtensionImmunohistochemistryPD-L1Papillary Thyroid CarcinomaPrognosis

Substanzen

B7-H1 Antigen

Autor:innen und Institutionen

  • Department of Pathology, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos, Porto Alegre, 2350, 90035-903, Rio Grande do Sul, Brazil. vitor_barretoo@hotmail.com.
  • Rio Grande Sul State Health Department, Porto Alegre, RS, Brazil.
  • Department of Pathology, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos, Porto Alegre, 2350, 90035-903, Rio Grande do Sul, Brazil.
  • Laboratory of Pathology, Genetics and Molecular Biology, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.

ORCID-Profile: Vitor Barreto Santana

Zitieren

APA

Santana, V. B., Krüger, V. M., Abrahão, M. C. Y., Cantú, P. L. M., Brackmann, R. L., Pandolfi, G. M., Marisco, L. S., Remonatto, G., Ferreira, L. A., & Graudenz, M. S. (2024). Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences PD-L1 Expression in Papillary Thyroid Carcinoma. Head and Neck Pathology. https://doi.org/10.1007/s12105-024-01618-5

Vancouver

Santana VB, Krüger VM, Abrahão MCY, Cantú PLM, Brackmann RL, Pandolfi GM, et al. Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences PD-L1 Expression in Papillary Thyroid Carcinoma. Head and Neck Pathology. 2024. doi:10.1007/s12105-024-01618-5

BibTeX
@article{Santana2024,
  author = {Santana, Vitor Barreto and Krüger, Vitória Machado and Abrahão, Maria Cristina Yunes and Cantú, Pietru Lentz Martins and Brackmann, Rosicler Luzia and Pandolfi, Gisele Moroni and Marisco, Liane Scheffler and Remonatto, Gabriela and Ferreira, Luciana Adolfo and Graudenz, Marcia Silveira},
  title = {Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences PD-L1 Expression in Papillary Thyroid Carcinoma},
  journal = {Head and Neck Pathology},
  year = {2024},
  doi = {10.1007/s12105-024-01618-5}
}
Kostenlos starten →